HomeCompareBFOCX vs JNJ

BFOCX vs JNJ: Dividend Comparison 2026

BFOCX yields 5.56% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BFOCX wins by $8.8K in total portfolio value
10 years
BFOCX
BFOCX
● Live price
5.56%
Share price
$35.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.8K
Annual income
$792.35
Full BFOCX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BFOCX vs JNJ

📍 BFOCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBFOCXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BFOCX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BFOCX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BFOCX
Annual income on $10K today (after 15% tax)
$472.35/yr
After 10yr DRIP, annual income (after tax)
$673.50/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $30.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BFOCX + JNJ for your $10,000?

BFOCX: 50%JNJ: 50%
100% JNJ50/50100% BFOCX
Portfolio after 10yr
$24.4K
Annual income
$810.07/yr
Blended yield
3.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BFOCX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BFOCX buys
0
JNJ buys
0
No recent congressional trades found for BFOCX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBFOCXJNJ
Forward yield5.56%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$28.8K$20.0K
Annual income after 10y$792.35$827.78
Total dividends collected$6.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BFOCX vs JNJ ($10,000, DRIP)

YearBFOCX PortfolioBFOCX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,256$555.71$10,676$355.77+$580.00BFOCX
2$12,628$584.57$11,407$389.39+$1.2KBFOCX
3$14,125$612.94$12,198$426.53+$1.9KBFOCX
4$15,755$640.75$13,056$467.62+$2.7KBFOCX
5$17,525$667.91$13,987$513.12+$3.5KBFOCX
6$19,446$694.38$14,998$563.56+$4.4KBFOCX
7$21,528$720.09$16,098$619.52+$5.4KBFOCX
8$23,780$745.01$17,295$681.69+$6.5KBFOCX
9$26,213$769.11$18,599$750.82+$7.6KBFOCX
10$28,841$792.35$20,022$827.78+$8.8KBFOCX

BFOCX vs JNJ: Complete Analysis 2026

BFOCXStock

The fund invests primarily in common stocks that are selected for their long-term growth potential. It may invest in companies of any size. The fund concentrates its investments in the electronic technology industry, which means more than 25%, and as much as 100%, of the fund's total assets can be invested in that particular industry. It may invest without limitation in foreign securities and certain types of exchange traded funds. The fund is non-diversified.

Full BFOCX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BFOCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BFOCX vs SCHDBFOCX vs JEPIBFOCX vs OBFOCX vs KOBFOCX vs MAINBFOCX vs ABBVBFOCX vs MRKBFOCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.